CAS No. |
51372-29-3 |
中文名称 |
7-羟基-8b-(2-羟基乙酰基)-6a,8a-二甲基-10-丙基-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-十二氢-4H-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烷-4-酮 |
英文名称 |
7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
别名 |
Dexbudesonide | R-Budesonide | 51372-29-3 | Dexbudesonide [INN] | 51333-22-3 | 2HI1006KPH | Pregna-1,4-diene-3,20-dione,16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11b,16a)- | (1~{s},2~{s},4~{r},6~{r},8~{s},9~{s},11~{s},12~{s},13~{r})-9,13-Dimethyl-11-Oxidanyl-8 |
标准英文名 |
7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
分子式 |
C25H34O6 |
分子量 |
430.54
|
精确分子量 |
430.24
|
SMILES |
CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1 |
标准SMILES |
CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO |
用途 |
Budesonide is a glucocorticoid with potent local anti-inflammatory and anti-allergic activity, primarily used as an inhaled corticosteroid for the prevention and treatment of asthma and allergic rhinitis. It enhances the stability of endothelial cells, smooth muscle cells, and lysosomal membranes; inhibits immune responses and antibody synthesis; reduces the release and activity of allergic mediators such as histamine; and suppresses the enzyme-mediated processes triggered by antigen-antibody interactions, thereby inhibiting the synthesis and release of bronchoconstrictive substances and alleviating smooth muscle contraction. Due to its high first-pass hepatic metabolism (~85–90%) and low systemic bioavailability, budesonide exerts strong local anti-inflammatory effects in the airways with minimal systemic side effects, making it particularly suitable for pediatric use. |
InChIKey |
VOVIALXJUBGFJZ-UHFFFAOYSA-N |